CLINICAL_TRIALS
trial_result
· 2020-10-01
Clinical Trial Update: A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine [Phase 2]
Summary
Phase 2 trial update for bryostatin in moderately to severely Alzheimer’s disease patients not on memantine has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Neurotrope Bioscience, Inc. | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-10-01